HER2 Low Breast Carcinoma

specific

A breast adenocarcinoma defined by low expression of HER2 (IHC1+ or IHC2+; FISH negative).

8

Centers

7

Active Trials

—

Cancer Funding

Top Centers for HER2 Low Breast Carcinoma(8)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
The University of Texas MD Anderson Cancer CenterHouston, TX
NCI Comprehensive
Active Research Program
59.1
2
The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL
NCI Comprehensive
Active Research Program
59.1
3
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
59.1
4
Moffitt Cancer CenterTampa, FL
NCI Comprehensive
Active Research Program
59.1
5
O’Neal Comprehensive Cancer Center at the University of Alabama at BirminghamBirmingham, AL
NCI Comprehensive
Active Research Program
59.1
6
University of Illinois Cancer CenterChicago, IL
Active Research Program
59.1
7
Cancer Center at IllinoisUrbana, IL
Active Research Program
59.1
8
Dana-Farber Cancer InstituteBoston, MA
NCI Comprehensive
36.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →